| Date | Title | Description |
| 19.09.2016 | EnteroMedics Announces Receipt of Notice of Intention to Grant European Patent | St. Paul, MN — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the European Patent Office has ... |
| 05.04.2016 | EnteroMedics Announces Publication of Results Showing Significantly Greater Weight Loss in vBloc Patients with Moderate Obesity | St. Paul, MN — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced the publication of results from the ... |
| 05.11.2015 | EnteroMedics Announces $25.0 million Registered Direct Offering of Convertible Notes | St. Paul, MN — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced it has entered into a securities pur... |
| 20.05.2015 | EnteroMedics Announces First US Commercial Implant of vBloc(R) Neurometabolic Therapy System at Tufts | St. Paul, MN — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced the first ever commercial implant of... |
| 07.04.2015 | EnteroMedics Announces Update on vBloc Therapy Trained Centers and Physicians | St. Paul, MN — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that 15 centers have been certified ... |
| 14.01.2015 | EnteroMedics Announces FDA Approval of VBLOC(R) Vagal Blocking Therapy for the Treatment of Obesity | St. Paul, MN — EnteroMedics Inc. (NASDAQ: ETRM) today announced that the U.S. Food and Drug Administration (FDA) has approved VBLOC® vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients with obesity... |
| 30.10.2014 | EnteroMedics Names Brad Hancock Chief Commercial Officer | St. Paul, MN — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Brad Hancock will join the Comp... |
| 29.09.2014 | EnteroMedics CE Mark for Obesity Expanded to Include Treatment of Type 2 Diabetes Mellitus | St. Paul, MN — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its CE Mark for the Maestro® Re... |
| 03.09.2014 | EnteroMedics’ ReCharge Pivotal Trial Results Published in the Journal of the American Medical Association | St. Paul, MN — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced the publication of results from the ... |
| 28.08.2014 | EnteroMedics Announces Three Year Diabetes, Hypertension and Weight Loss Data from the Maestro(R) RC System DM2 ENABLE Study | St. Paul, MN — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, announced that three year diabetes, hypertension and... |
| 03.12.2013 | EnteroMedics Announces 18 Month ReCharge Study Results | December 3, 2013
ST. PAUL, MN — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced 18 month efficacy ... |
| 28.11.2013 | Five innovative obesity treatments as America prepares to unbutton its post-Thanksgiving pants | ReShape Medical has created a dual-balloon that’s inflated in the stomach to make a patient feel full, and couples the device with a program that focuses on nutrition and behavioral changes. It’s for patients with BMIs between 30 and 40, ra... |
| 04.03.2013 | Weight loss: EnteroMedics closes $13M round | Wall Street Beat | EnteroMedics (NSDQ:ETRM) said it closed a public offering it expects to add about $12 million to its coffers after it pays off expenses.
The St. Paul, Minn.-based medical device company is developing technology to treat obesity using neuros... |
| 20.04.2012 | EnteroMedics is like a cat with nine lives. Will FDA make it immortal? | Fast forward to 2012.
The Roseville, Minnesota company announced last month that it is commercializing the next generation of the Maestro device in Australia and has signed a distribution agreement with a partner in Saudi Arabia to sell it ... |
| 05.04.2012 | Obesity treatment firm begins commercializing neurostimulation device | The Minnesota device maker also announced that it has signed a multiyear distribution agreement with a Saudi enterprise to sell the Maestro system in the Gulf countries.
While EnteroMedics is making headway abroad, it has still a ways to go... |
| 06.09.2011 | The MassDevice Weekly Checkup: Sept. 6, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 29.08.2011 | The MassDevice Weekly Checkup: August 29, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 15.08.2011 | The MassDevice Weekly Checkup: August 15, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 08.08.2011 | The MassDevice Weekly Checkup: August 8, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 25.07.2011 | The MassDevice Weekly Checkup: July 25, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 27.06.2011 | The MassDevice Weekly Checkup: June 27, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 06.06.2011 | The MassDevice Weekly Checkup: June 6, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 23.05.2011 | The MassDevice Weekly Checkup: May 23, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 16.05.2011 | The MassDevice Weekly Checkup: May 16, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 27.04.2011 | BD profits increase 5 percent on sales growth | Earnings roundup | MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundo... |
| 26.04.2011 | Weight loss device: EnteroMedics to implant first U.S. patient in new study | EnteroMedics Inc. (NSDQ:ETRM) said yesterday that it expects to enroll the first patient in a clinical trial for its new obesity controlling therapy by the end of the second quarter and have enrollment completed by year’s end.
The announcem... |
| 25.04.2011 | EnteroMedics expects to complete obesity device implants in US by end 2011 | The company believes that its Maestro system is the first obesity therapy under clinical evaluation to regulate or block the vagus nerves. VBLOC therapy is delivered through laparoscopically implanted leads to intermittently block vagal ner... |
| 25.04.2011 | The MassDevice Weekly Checkup: April 25, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 29.03.2011 | FDA clears Abbott’s wireless handheld testing system | Regulatory roundup | The FDA granted Abbott Laboratories (NYSE:ABT) 510(k) clearance for the wireless version of its i-STAT 1 point of care testing system.
Healthcare providers use the Abbott Park, Ill.-based company’s handheld i-STAT 1 device to transmit diagn... |
| 28.03.2011 | The MassDevice Weekly Checkup: March 28, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 28.03.2011 | EnteroMedics Receives CE Mark Certification for the Maestro RC System, Allowing Australian Regulatory Application to Move Forward | March 28, 2011
St. Paul, MN — EnteroMedics Inc., (NASDAQ: ETRM), the sole developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that it has received CE Mark appro... |
| 21.03.2011 | The MassDevice Weekly Checkup: March 21, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 08.02.2011 | The MassDevice Weekly Checkup: February 8, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 23.01.2011 | The MassDevice Weekly Checkup: January 25, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 05.01.2011 | The MassDevice Weekly Checkup: January 5, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 21.12.2010 | The MassDevice Weekly Checkup: December 21, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 15.12.2010 | EnteroMedics raises $29.8M as part of stunning turnaround | EnteroMedics’ most recent offering seems to reflect its growing confidence in winning approval from the Food & Drug Administration for its Maestro device, which uses electricity to control hunger by blocking nerve signals between the br... |
| 15.12.2010 | EnteroMedics closes $30 million public offering | EnteroMedics Inc. (NSDQ:ETRM) closed its $29.8 million public offering of 17 million shares of common stock and 17 million corresponding warrants.
The St. Paul, Minn.-based anti-obesity device maker plans to use the $27.6 million it netted ... |
| 23.11.2010 | The MassDevice Weekly Checkup: November 23, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 11.11.2010 | EnteroMedics in full fundraising mode; offers to sell 12M shares | Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has nev... |
| 11.11.2010 | EnteroMedics looks to pull in $24 million in public offering | Hoping to push its groundbreaking obesity-fighting device across the proverbial finish line, EnteroMedics Inc. (NSDQ:ETRM) is selling 12 million new shares to the public, according to a Securities & Exchange Commission filing.
If the sa... |
| 28.09.2010 | The MassDevice Weekly Checkup: September 28, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 31.08.2010 | The MassDevice Weekly Checkup: August 31, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 07.07.2010 | The MassDevice Weekly Checkup: July 6, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 29.06.2010 | The MassDevice Weekly Checkup: June 29, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 22.06.2010 | The MassDevice Weekly Checkup: June 22, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 08.06.2010 | The MassDevice Weekly Checkup: June 8, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 20.05.2010 | The MassDevice Weekly Checkup: May 18, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 11.05.2010 | The MassDevice Weekly Checkup: May 11, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 05.05.2010 | Minnesota’s medical device cluster consolidates | By Thomas Lee
Ernie Andberg has a little more free time on his hands these days.
The longtime “emerging medical device companies” equity analyst for Feltl & Co. in Minneapolis has not seen a lot of companies emerging lately.
In fact, th... |
| 05.04.2010 | The MassDevice Weekly Checkup: April 6, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 22.03.2010 | The MassDevice Weekly Checkup: March 23, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 18.02.2010 | EnteroMedics CEO: Don’t lump us in with failed Leptos Biomedical | Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has nev... |
| 15.01.2010 | EnteroMedics Inc.’s fate now in the hands of the FDA. Your guess is as good as mine. | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently during uncertain times.
SAP
Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recov... |
| 29.12.2009 | Annual Checkup: The gainers and losers in medical device stocks this year | All year our Weekly Checkup calculated the biggest gainers and losers among publicly traded medical device companies, comparing Monday morning’s opening share prices with their value when the markets close each Friday afternoon. As 2009 dra... |
| 07.02.2008 | IPO roundup: Is the window slamming on life sciences? | It’s sure starting to look that way. News that Archemix, a Cambridge, Mass., developer of aptamer-based drugs, yesterday withdrew its $72.5 million IPO follows closely on the heels of several other recent several other IPO collapses, includ... |
| 14.11.2007 | EnteroMedics and its risky obesity device, the latest victims of the IPO haircut | (UPDATED: See below.)
(NOTE: This item was originally published as part of today’s life-sciences briefing.)
EnteroMedics, a St. Paul, Minn., device maker working on a neuromodulation implant for treating obesity, slashed its expected IPO pr... |
| 26.10.2007 | Life sciences briefing: Friday, Oct. 26, 2007 | Featured companies: Allozyne, Arteriocyte Medical Systems, Arthrosurface, Bay City Capital, EnteroMedics, OncoVista, Novotech, Power Medical Interventions, Reliant Technologies
UPDATED: Expanded items on Allozyne, Reliant Tech, Power Medica... |
| 16.08.2007 | Life sciences briefing: Thursday, Aug. 16, 2007 | Featured companies: Reliant Technologies, Leptos Biomedical, Calidora Skin Clinic
Reliant Tech seeks $95M IPO for dermatology lasers — Mountain View, Calif.-based Reliant Technologies, a developer of medical lasers for “skin rejuvenation” t... |
| 29.05.2007 | EnteroMedics plans $86M IPO for obesity-control implants | EnteroMedics, a St. Paul, Minn., developer of obesity-treatment implants, filed to raise up to $86.25 million in an IPO. Its S-1 filing with the SEC is here.
The company is developing a neuromodulation implant called VBLOC that is designed ... |
| - | EnteroMedics CEO: Don’t lump us in with failed Leptos Biomedical | ROSEVILLE, Minnesota — EnteroMedics Inc. already faces plenty of doubters on Wall Street. So not surprisingly, the company was not too happy with a recent story I wrote suggesting Leptos Biomedical Inc.’s demise had something to do with En... |
| - | EnteroMedics raises $29.8M as part of stunning turnaround | EnteroMedics Inc. (NASDAQ:ETRM) closed its $29.8 million public offering of 17 million shares of common stock and 17 million corresponding warrants.
The St. Paul, Minnesota-based anti-obesity device maker plans to use the $27.6 million it n... |
| - | EnteroMedics is like a cat with nine lives. Will FDA make it immortal? | Analyst Debbie Wang of Morningstar remembers that day in October 2009 when obesity treatment firm EnteroMedics (NASDAQ:ETRM) held a conference call to explain that its highly anticipated Maestro device had failed to meet a goal in a clinica... |
| - | EnteroMedics in full fundraising mode; offers to sell 12M shares | Hoping to push its groundbreaking obesity-fighting device across the proverbial finish line, EnteroMedics Inc. (NASDAQ:ETRM) is selling 12 million new shares to the public, according to documents recently filed with the Securities and Excha... |
| - | EnteroMedics expects to complete obesity device implants in US by end 2011 | Roseville, Minnesota-based EnteroMedics said Monday, that it expects to implant its first patient with its obesity controlling therapy by the second quarter of the year and all implants completed by year end.
The announcement was part of th... |
| - | Five innovative obesity treatments as America prepares to unbutton its post-Thanksgiving pants | You’ve cracked open the crate of cranberries, stuck the turkey in the oven and are well into filling your second muffin tin with cornbread batter. And just in time for dinner, MedCity is here to talk about innovative obesity treatments, bot... |
| - | EnteroMedics Inc.’s fate now in the hands of the FDA. Your guess is as good as mine. | ROSEVILLE, Minnesota– What to do if you’re an EnteroMedics Inc. investor?
The company, which is developing a device that uses electricity to treat obesity and diabetes, Thursday said data from a key clinical trial showed its VBLOC therapy “... |
| - | Obesity treatment firm begins commercializing neurostimulation device | Obese Australians will be among the first in the world to use a Minnesota company’s therapy that uses an implantable neurostimulator to achieve weight loss.
EnteroMedics (NASDAQ:ETRM) announced this week that it has shipped its first commer... |
